Search Within

Weinberg Fellows

Formats
  1. Meeting Abstract (1232)
  2. Journal Article (1043)
  3. Review (105)
  4. Editorial (53)
  5. Research Letter (29)
  6. Book Section (22)
  7. Correspondence (20)
  8. Guidelines (11)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (2425)
  2. Solid Tumor Oncology Division (1852)
  3. Hematologic Malignancies, Division of (1168)
  4. GSK Faculty (1105)
  5. Department of Pathology and Laboratory Medicine (907)
  6. Epidemiology and Biostatistics (839)

More Groups

People
  1. Michael Berger (215)
  2. Marc Ladanyi (190)
  3. Pedram Razavi (175)
  4. Michael Offin (171)
  5. David Solit (166)
  6. Maria Carlo (164)

More People

Years
  1. 2025 (115)
  2. 2024 (358)
  3. 2023 (292)
  4. 2022 (347)
  5. 2021 (307)
  6. 2020 (307)

More Years

Publications
  1. Journal of Clinical Oncology (534)
  2. Blood (236)
  3. Annals of Oncology (98)
  4. Clinical Cancer Research (94)
  5. Journal of Thoracic Oncology (81)
  6. Cancer Research (80)

More Publications

Publishers
  1. American Society of Clinical Oncology (603)
  2. Elsevier Inc. (353)
  3. American Society of Hematology (269)
  4. American Association for Cancer Research (216)
  5. Nature Publishing Group (172)
  6. Oxford University Press (147)

More Publishers

Results (2518)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses
    Meeting Abstract

    Doshi, S. D.; Sanmiguel, A. L.; Knezevic, A.; Kotecha, R. R.; Shah, N. J.; Carlo, M.; Feldman, D. R.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Local definitive therapy (LDT) utilization patterns and outcomes in chromophobe renal cell carcinoma (chRCC) with metachronous metastasis: A multi-institution study
    Meeting Abstract

    Dizman, N.; Doshi, S. D.; Knezevic, A.; Feinaj, A.; Sayegh, N.; Hobeika, C.; Alaghehbandan, R.; Rives, H.; Zengin, Z. B.; Braun, D. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Investigation of ferroptosis and mTOR signaling in chromophobe renal cell carcinoma (ChRCC)
    Meeting Abstract

    Madsen, K. N.; Labaki, C.; Saad, E.; Alchoueiry, M.; Bi, K.; Hobeika, C.; Bakouny, Z.; Priolo, C.; Khabibullin, D.; Schindler, N. R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Association between clonal hematopoiesis and survival after nephrectomy in patients with renal cell carcinoma
    Meeting Abstract

    Khandwala, Y.; Ruthen, N.; Kotecha, R. R.; Russo, P.; Coleman, J.; Reznik, E.; Hakimi, A. A.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Characterizing the immune effects of enfortumab vedotin (EV) on peripheral blood mononuclear cells (PBMCs) in metastatic urothelial cancer patients (mUC)
    Meeting Abstract

    Gupta, A.; Sevilla, C.; Pihlstrom, N. L.; Liang, S.; Regazzi, A. M.; McCoy, A. S.; Maher, C. A.; Wong, P.; Ahmed, F.; Funt, S. A.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Safety and clinical activity of daraxonrasib (RMC-6236) in RAS mutant non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Punekar, S. R.; Hong, D. S.; Luo, J.; Ou, S. H. I.; Johnson, M. L.; Spira, A.; Garrido-Laguna, I.; Goldman, J. W.; Herzberg, B.; Saltos, A.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Enhancing enrollment to 1L NSCLC trials by allowing 1 prior cycle of standard of care (SOC): SUNRAY-01 experience
    Meeting Abstract

    Hochmair, M. J.; Arbour, K. C.; Negrao, M. V.; Cappuzzo, F.; Dingemans, A. M. C.; Girard, N.; Gronberg, B. H.; Leal, T. A.; Lindsay, C.; Lu, S.; more...
    Journal of Thoracic Oncology (2025)

    Fulltext@MSK | Save
  • Artificial intelligence to enhance precision medicine in cardio-oncology: A scientific statement from the American Heart Association
    Guidelines

    Khera, R.; Asnani, A. H.; Krive, J.; Addison, D.; Zhu, H.; Vasbinder, A.; Fleming, M. R.; Arnaout, R.; Razavi, P.; Okwuosa, T. M.; more...
    Circulation-Genomic and Precision Medicine (2025)

    Fulltext@MSK | Save
  • Can longitudinal biomarkers guide treatment decisions? Time will tell
    Editorial

    Jeng, M. Y.; Schoenfeld, A. J.
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
    Journal Article

    Sethna, Z.; Guasp, P.; Reiche, C.; Milighetti, M.; Ceglia, N.; Patterson, E.; Lihm, J.; Payne, G.; Lyudovyk, O.; Rojas, L. A.; more...
    Nature (2025)

    Fulltext@MSK | Save